| RS886041087 |
TBCD
|
Health Risk |
Pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS886041088 |
FMR1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS886041089 |
FMR1
|
Health Risk |
Pathogenic |
Intellectual disability, Nonpapillary renal cell carcinoma |
| RS886041090 |
BRPF1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS886041091 |
NTRK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 58 |
| RS886041093 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS886041094 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, infantile |
| RS886041095 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS886041097 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS886041100 |
AKT3
|
Health Risk |
Likely pathogenic |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 |
| RS886041102 |
L1CAM
|
Health Risk |
Likely pathogenic |
X-linked hydrocephalus syndrome, X-linked hydrocephalus syndrome |
| RS886041106 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS886041108 |
SLC12A3
|
Health Risk |
Pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS886041111 |
ZIC3
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS886041114 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, Autosomal dominant polycystic kidney disease |
| RS886041116 |
ADNP
|
Health Risk |
Pathogenic/Likely pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, 8 conditions |
| RS886041121 |
CYP11A1
|
Health Risk |
Likely pathogenic |
Congenital adrenal insufficiency with 46, XY sex reversal OR 46 |
| RS886041122 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, ACAT1-related disorder |
| RS886041123 |
AIRE
|
Health Risk |
Pathogenic |
— |
| RS886041124 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS886041125 |
ANKRD11
|
Health Risk |
Pathogenic/Likely pathogenic |
KBG syndrome, 8 conditions |
| RS886041126 |
AP4M1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 50, Spastic paraplegia |
| RS886041127 |
AP4S1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 52 |
| RS886041128 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS886041129 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS886041130 |
AR
|
Health Risk |
Pathogenic |
— |
| RS886041131 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS886041132 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS886041133 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS886041134 |
ARSL
|
Health Risk |
Pathogenic |
— |
| RS886041135 |
ARSL
|
Health Risk |
Pathogenic |
— |
| RS886041138 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS886041139 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS886041141 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Vitelliform macular dystrophy 2 |
| RS886041142 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive bestrophinopathy, BEST1-related disorder |
| RS886041144 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS886041145 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS886041146 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS886041147 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS886041148 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS886041149 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS886041153 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS886041154 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS886041157 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS886041158 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS886041161 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS886041162 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS886041163 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886041166 |
CHD7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, CHARGE syndrome |
| RS886041167 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886041169 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886041170 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886041172 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS886041173 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS886041174 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS886041175 |
CHM
|
Health Risk |
Pathogenic |
CHM-related disorder, CHM-related disorder |
| RS886041176 |
CHM
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS886041177 |
CHM
|
Health Risk |
Pathogenic |
Retinal dystrophy, Choroideremia |
| RS886041178 |
CHM
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS886041179 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Retinal dystrophy |
| RS886041180 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS886041181 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS886041184 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, VPS13B-related disorder |
| RS886041185 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Inborn genetic diseases |
| RS886041186 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Epidermolysis bullosa dystrophica |
| RS886041187 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS886041188 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886041189 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886041190 |
CSRP3
|
Health Risk |
Pathogenic |
— |
| RS886041191 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886041192 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS886041193 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886041194 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS886041195 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886041197 |
EEF1A2
|
Health Risk |
Pathogenic |
EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy, Intellectual disability |
| RS886041199 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS886041200 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4H |
| RS886041201 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS886041202 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS886041203 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Pneumothorax - familial |
| RS886041204 |
INPP5E
|
Health Risk |
Pathogenic |
— |
| RS886041205 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS886041207 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS886041209 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Inborn genetic diseases |
| RS886041211 |
LMNA
|
Health Risk |
Pathogenic |
— |
| RS886041212 |
LORICRIN
|
Health Risk |
Pathogenic |
Loricrin keratoderma, Loricrin keratoderma |
| RS886041213 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS886041214 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS886041215 |
NR0B1
|
Health Risk |
Pathogenic |
— |
| RS886041216 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Inborn genetic diseases |
| RS886041217 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS886041218 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS886041219 |
NSD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Sotos syndrome, NSD1-related disorder |
| RS886041220 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS886041221 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS886041222 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS886041223 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041224 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041225 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Thyroid cancer |
| RS886041226 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, PHEX-related disorder |